Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 7376 - 7400 of 7899 in total
Experimental
Experimental
Balhimycin is a novel glycopeptide antibiotic.
Experimental
Matched Iupac: … {34,39}]pentaconta-3,5,8,10,12(48),14,16,29,31,33(45),34(39),35,37,46,49-pentadecaene-40-carboxylic acid
Dihematoporphyrin ether is under investigation in clinical trial NCT00118222 (High Light and Low Light Dose PDT in Glioma).
Investigational
Matched Iupac: … 16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1(20),2,4,6(24),7,9,11,13(22),14,16,18-undecaen-4-yl]propanoic acid
Experimental
Experimental
Matched Iupac: … hydroxy-3,5-bis({[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxane-2-carboxylic acid ... hydroxy-3,5-bis({[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})oxane-2-carboxylic acid
GSI-136 has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Experimental
Experimental
Experimental
Glibornuride is a sulfonylurea-type anti-diabetic drug.
Investigational
Withdrawn
UK-390,957 has been used in trials studying the treatment of Ejaculation.
Investigational
Experimental
Distigmine is a parasympathomimetic agent with a longer duration of action and enhanced drug accumulation compared to DB00545 and DB01400. It is an anticholinergic drug and long-acting reversible carbamate cholinesterase inhibitor that binds directly and competitively to the agonist binding sites of muscurinic receptors. Distigmine is available in several countries...
Experimental
Investigational
Displaying drugs 7376 - 7400 of 7899 in total